Team DoctorNDTV | Monday March 19, 2001
GlaxoSmithKline are on the verge of developing a cheap anti-malarial drug, LAPDAP, in collaboration with the World Health Organisation (WHO), for use in the under-developed countries.
Malaria is an infectious disease caused by the female anopheles mosquito, and is still rampant in Africa and India. Though it is eminently treatable, the medicines m...
doctor.ndtv.com